HongShan Leads in Brain Tech, NeuroRevix
29 Sep 2026
US$ 20.00
HongShan Capital Group has led the angel financing round of Beijing Tianfukang Medical Technology Co Ltd, operating as...
Tag
HealthTech
Related Publications
South Korea is expanding the role of its sovereign wealth fund (SWF) as the government seeks to mobilise long-term...
Despite its long history in the private equity/venture capital industry, a foreign-sponsored dedicated Japan private...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.